title: Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis.
authors.forename: H
authors.initials: H
authors.lastname: Hashizume
authors.forename: H
authors.initials: H
authors.lastname: Yagi
authors.forename: A
authors.initials: A
authors.lastname: Ohshima
authors.forename: T
authors.initials: T
authors.lastname: Ito
authors.forename: N
authors.initials: N
authors.lastname: Horibe
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshinari
authors.forename: M
authors.initials: M
authors.lastname: Takigawa
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000009:adverse effects; D005260:Female; D006561:Herpes Simplex / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000276:immunology*; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus